One detail, the rare disease that responds to T+B (BTBGD) coincides with HD, not only in the striatal atrophy, but in the triggering decreased function of the thiamine brain transporter (SLC19A3), mutated in BTBGD and under-expressed in HD)!! Which really sparked the initiative!